Agios Pharmaceuticals, Inc. (AGIO) stock
AGIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/308% above fair value
$29.68−0.21 (-0.70%)
Close on Nov 18, 2026Market cap $1.77BP/E –Yield –
Agios Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Agios Pharmaceuticals's revenue for the twelve months ending Jun 30, 2026 was $98.34M, up 140.6% year over year. For fiscal 2025 it was $54.03M, up 48.0% from the year before. Over ten years it grew -0.9% a year on average. The highest annual figure on record is $117.91M in fiscal 2019.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $54.03M | +48.0% |
| FY2024 | Dec 31, 2024 | $36.50M | +36.1% |
| FY2023 | Dec 31, 2023 | $26.82M | +88.4% |
| FY2022 | Dec 31, 2022 | $14.24M | – |
| FY2021 | Dec 31, 2021 | $0 | – |
| FY2020 | Dec 31, 2020 | $0 | -100.0% |
| FY2019 | Dec 31, 2019 | $117.91M | +24.9% |
| FY2018 | Dec 31, 2018 | $94.39M | +119.4% |
| FY2017 | Dec 31, 2017 | $43.01M | -38.5% |
| FY2016 | Dec 31, 2016 | $69.89M | +18.2% |
| FY2015 | Dec 31, 2015 | $59.12M | -9.5% |
| FY2014 | Dec 31, 2014 | $65.36M | +155.8% |
| FY2013 | Dec 31, 2013 | $25.55M | +1.8% |
| FY2012 | Dec 31, 2012 | $25.11M | +15.0% |
| FY2011 | Dec 31, 2011 | $21.84M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $44.75M | +259.3% |
| Q1 FY2026 | Mar 31, 2026 | $20.75M | +137.7% |
| Q4 FY2025 | Dec 31, 2025 | $19.97M | +86.1% |
| Q3 FY2025 | Sep 30, 2025 | $12.88M | +43.7% |
| Q2 FY2025 | Jun 30, 2025 | $12.46M | +44.6% |
| Q1 FY2025 | Mar 31, 2025 | $8.73M | +6.6% |
| Q4 FY2024 | Dec 31, 2024 | $10.73M | +51.1% |
| Q3 FY2024 | Sep 30, 2024 | $8.96M | +21.2% |
| Q2 FY2024 | Jun 30, 2024 | $8.62M | +28.4% |
| Q1 FY2024 | Mar 31, 2024 | $8.19M | +46.0% |
| Q4 FY2023 | Dec 31, 2023 | $7.10M | +64.8% |
| Q3 FY2023 | Sep 30, 2023 | $7.40M | +110.4% |
| Q2 FY2023 | Jun 30, 2023 | $6.71M | +20.2% |
| Q1 FY2023 | Mar 31, 2023 | $5.61M | +574.2% |
| Q4 FY2022 | Dec 31, 2022 | $4.31M | – |
| Q3 FY2022 | Sep 30, 2022 | $3.52M | – |
| Q2 FY2022 | Jun 30, 2022 | $5.58M | – |
| Q1 FY2022 | Mar 31, 2022 | $832.00K | – |
| Q4 FY2021 | Dec 31, 2021 | $0 | -100.0% |
| Q3 FY2021 | Sep 30, 2021 | $0 | -100.0% |
| Q2 FY2021 | Jun 30, 2021 | $0 | -100.0% |
| Q1 FY2021 | Mar 31, 2021 | $0 | -100.0% |
| Q4 FY2020 | Dec 31, 2020 | $44.05M | +24.3% |
| Q3 FY2020 | Sep 30, 2020 | $34.71M | +33.4% |
| Q2 FY2020 | Jun 30, 2020 | $37.35M | +42.4% |
| Q1 FY2020 | Mar 31, 2020 | $87.10M | +188.1% |
| Q4 FY2019 | Dec 31, 2019 | $35.44M | +18.1% |
| Q3 FY2019 | Sep 30, 2019 | $26.02M | +71.2% |
| Q2 FY2019 | Jun 30, 2019 | $26.22M | -35.1% |
| Q1 FY2019 | Mar 31, 2019 | $30.23M | +245.0% |
| Q4 FY2018 | Dec 31, 2018 | $30.01M | +206.3% |
| Q3 FY2018 | Sep 30, 2018 | $15.20M | +33.8% |
| Q2 FY2018 | Jun 30, 2018 | $40.41M | +256.2% |
| Q1 FY2018 | Mar 31, 2018 | $8.76M | -16.6% |
| Q4 FY2017 | Dec 31, 2017 | $9.80M | -56.7% |
| Q3 FY2017 | Sep 30, 2017 | $11.36M | +26.4% |
| Q2 FY2017 | Jun 30, 2017 | $11.35M | – |
| Q1 FY2017 | Mar 31, 2017 | $10.51M | – |
| Q4 FY2016 | Dec 31, 2016 | $22.65M | – |
| Q3 FY2016 | Sep 30, 2016 | $8.99M | – |
See a number that looks wrong?